{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:57:08Z","timestamp":1781643428419,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH","award":["K12TR004384"],"award-info":[{"award-number":["K12TR004384"]}]},{"name":"NIH","award":["T32HL155020"],"award-info":[{"award-number":["T32HL155020"]}]},{"name":"NIH","award":["U54GM115516"],"award-info":[{"award-number":["U54GM115516"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Toxicologists may use high dose n-acetylcysteine (HD-NAC) for early-treated high-risk acetaminophen ingestions (EHRAI) given concerns over standard NAC (S-NAC) dosing\u2019s efficacy. We utilize the novel, clinically relevant outcome of mean additional 16-hour NAC maintenance infusions (NMI) to evaluate differences in treatment duration for EHRAI patients treated with S-NAC versus HD-NAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective multistate poison center study from 1\/1\/2019-7\/4\/2024 of patients\u2009\u2265\u200913-years-old who were treated with S-NAC or HD-NAC within eight hours of a high-risk acetaminophen ingestion. The primary outcome was mean additional NMI. Secondary outcomes were NAC infusion duration, hepatotoxicity, coagulopathy, transplant, and death. Sensitivity analyses evaluated for robustness of findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 127 included cases, 52.0% (66\/127) received HD-NAC. 7.1% (9\/127) had anti-peristaltic co-ingestions. HD-NAC cases received more fomepizole (23.1% versus 1.6%; difference 21.1%). Acetaminophen concentrations controlled for time since ingestion were similar (mean acetaminophen ratio for HD-NAC: 2.7, IQR: 2.3, 3.3 versus S-NAC: 2.4, IQR: 2.2, 2.7; difference\u2009\u2212\u20090.3). 26.0% (33\/127) received NMI solely for residual detectable serum acetaminophen. There was no difference in mean additional NMI (HD-NAC: 0.53 versus S-NAC: 0.38;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.240). Median NAC infusion durations were equal across groups (21.0; IQR: 21.0, 37.0; difference 0.0) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.137). One patient per group developed hepatotoxicity; there were no transplants or deaths. Sensitivity analyses yielded similar results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found no difference in mean NMI for EHRAI based on NAC dose. These findings support additional NMI as an objective, common, clinically relevant outcome for acetaminophen toxicity research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s13181-026-01129-5","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:41:07Z","timestamp":1773938467000},"page":"253-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["N-Acetylcysteine Dose and Treatment Duration in High-Risk Acetaminophen Ingestions Treated Within Eight Hours: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"22","author":[{"given":"C. James","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishita","family":"Saraiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Wilkosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele M.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Neavyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania D.","family":"Strout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"10201","key":"1129_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0140-6736(19)31894-X","volume":"394","author":"RT Stravitz","year":"2019","unstructured":"Stravitz RT, Lee WM. Acute liver failure. Lancet. 2019;394(10201):869\u201381. https:\/\/doi.org\/10.1016\/S0140-6736(19)31894-X.","journal-title":"Lancet"},{"issue":"12","key":"1129_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/15563650.2025.2571299","volume":"63","author":"MC Beuhler","year":"2025","unstructured":"Beuhler MC, Feldman R, Gummin DD et al. 2024 Annual report of the national poison data system\u00ae (NPDS) from America\u2019s Poison Centers\u00ae: 42nd annual report. Clin Toxicol. 2025;63(12):1029\u20131280. https:\/\/doi.org\/10.1080\/15563650.2025.2571299","journal-title":"Clin Toxicol"},{"issue":"8","key":"1129_CR3","doi-asserted-by":"publisher","first-page":"e2327739","DOI":"10.1001\/jamanetworkopen.2023.27739","volume":"6","author":"RC Dart","year":"2023","unstructured":"Dart RC, Mullins ME, Matoushek T, et al. Management of acetaminophen poisoning in the US and canada: A consensus statement. JAMA Netw Open. 2023;6(8):e2327739. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.27739.","journal-title":"JAMA Netw Open"},{"issue":"24","key":"1129_CR4","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/nejm198812153192401","volume":"319","author":"M Smilkstein","year":"1988","unstructured":"Smilkstein M, Knapp G, Kulig K, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the National multicenter study (1976 to 1985). N Engl J Med. 1988;319(24):1557\u201362. https:\/\/doi.org\/10.1056\/nejm198812153192401.","journal-title":"N Engl J Med"},{"issue":"10","key":"1129_CR5","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1185\/030079907X219715","volume":"23","author":"IM Whyte","year":"2007","unstructured":"Whyte IM, Francis B, Dawson AH. Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter area toxicology service (HATS) database. Curr Med Res Opin. 2007;23(10):2359\u201368. https:\/\/doi.org\/10.1185\/030079907X219715.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"1129_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/15563650.2012.659252","volume":"50","author":"BH Rumack","year":"2012","unstructured":"Rumack BH, Bateman DN. Acetaminophen and acetylcysteine dose and duration: Past, present and future. Clin Toxicol. 2012;50(2):91\u20138. https:\/\/doi.org\/10.3109\/15563650.2012.659252.","journal-title":"Clin Toxicol"},{"issue":"8","key":"1129_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1080\/15563650.2019.1579914","volume":"57","author":"RG Hendrickson","year":"2019","unstructured":"Hendrickson RG. What is the most appropriate dose of N-acetylcysteine after massive acetaminophen overdose? Clin Toxicol. 2019;57(8):686\u201391. https:\/\/doi.org\/10.1080\/15563650.2019.1579914.","journal-title":"Clin Toxicol"},{"issue":"5","key":"1129_CR8","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1136\/emj.2006.043216","volume":"24","author":"C Bourdeaux","year":"2007","unstructured":"Bourdeaux C, Bewley J. Death from Paracetamol overdose despite appropriate treatment with N-acetylcysteine. Emerg Med J. 2007;24(5):e31\u201331. https:\/\/doi.org\/10.1136\/emj.2006.043216.","journal-title":"Emerg Med J"},{"issue":"9","key":"1129_CR9","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1345\/aph.1K680","volume":"42","author":"SW Smith","year":"2008","unstructured":"Smith SW, Howland MA, Hoffman RS, Nelson LS. Acetaminophen overdose with altered acetaminophen pharmacokinetics and hepatotoxicity associated with premature cessation of intravenous N-acetylcysteine therapy. Ann Pharmacother. 2008;42(9):1333\u20139. https:\/\/doi.org\/10.1345\/aph.1K680.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"1129_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.annemergmed.2008.10.001","volume":"54","author":"EA Schwartz","year":"2009","unstructured":"Schwartz EA, Hayes BD, Sarmiento KF. Development of hepatic failure despite use of intravenous acetylcysteine after a massive ingestion of acetaminophen and diphenhydramine. Ann Emerg Med. 2009;54(3):421\u20133. https:\/\/doi.org\/10.1016\/j.annemergmed.2008.10.001.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"1129_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1553-2712.2008.00296.x","volume":"16","author":"S Doyon","year":"2009","unstructured":"Doyon S, Klein-Schwartz W. Hepatotoxicity despite early administration of intravenous N-acetylcysteine for acute acetaminophen overdose. Acad Emerg Med. 2009;16(1):34\u20139. https:\/\/doi.org\/10.1111\/j.1553-2712.2008.00296.x.","journal-title":"Acad Emerg Med"},{"issue":"3","key":"1129_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s13181-010-0083-9","volume":"6","author":"RG Hendrickson","year":"2010","unstructured":"Hendrickson RG, McKeown NJ, West PL, Burke CR. Bactrian (double hump) acetaminophen pharmacokinetics: A case series and review of the literature. J Med Toxicol. 2010;6(3):337\u201344. https:\/\/doi.org\/10.1007\/s13181-010-0083-9.","journal-title":"J Med Toxicol"},{"issue":"4","key":"1129_CR13","doi-asserted-by":"publisher","first-page":"e1077","DOI":"10.1542\/peds.2010-2521","volume":"127","author":"GS Wang","year":"2011","unstructured":"Wang GS, Monte A, Bagdure D, Heard K. Hepatic failure despite early acetylcysteine following large acetaminophen-diphenhydramine overdose. Pediatrics. 2011;127(4):e1077\u201380. https:\/\/doi.org\/10.1542\/peds.2010-2521.","journal-title":"Pediatrics"},{"issue":"10","key":"1129_CR14","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/15563650.2017.1334915","volume":"55","author":"AL Chiew","year":"2017","unstructured":"Chiew AL, Isbister GK, Kirby KA, Page CB, Chan BSH, Buckley NA. Massive Paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol. 2017;55(10):1055\u201365. https:\/\/doi.org\/10.1080\/15563650.2017.1334915.","journal-title":"Clin Toxicol"},{"issue":"5","key":"1129_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5694\/mja15.00614","volume":"203","author":"AL Chiew","year":"2015","unstructured":"Chiew AL, Fountain JS, Graudins A, Isbister GK, Reith D, Buckley NA. Summary statement: new guidelines for the management of Paracetamol poisoning in Australia and new Zealand. Med J Aust. 2015;203(5):215\u20138. https:\/\/doi.org\/10.5694\/mja15.00614.","journal-title":"Med J Aust"},{"issue":"4","key":"1129_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5694\/mja2.50428","volume":"212","author":"AL Chiew","year":"2020","unstructured":"Chiew AL, Reith D, Pomerleau A, et al. Updated guidelines for the management of Paracetamol poisoning in Australia and new Zealand. Med J Aust. 2020;212(4):175\u201383. https:\/\/doi.org\/10.5694\/mja2.50428.","journal-title":"Med J Aust"},{"issue":"4","key":"1129_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/15563650.2021.1984503","volume":"60","author":"JC Lewis","year":"2022","unstructured":"Lewis JC, Lim M, Lai L, Mendoza E, Albertson TE, Chenoweth JA. Evaluation of N-acetylcysteine dose for the treatment of massive acetaminophen ingestion. Clin Toxicol. 2022;60(4):507\u201313. https:\/\/doi.org\/10.1080\/15563650.2021.1984503.","journal-title":"Clin Toxicol"},{"key":"1129_CR18","unstructured":"McElroy N, Filkins P, Hon S, Carpenter J. Increased acetylcysteine dosing in early, acute massive acetaminophen ingestion has minimal impact on patient outcomes. Presented at: North American Congress of Clinical Toxicology (NACCT); 2023."},{"issue":"8","key":"1129_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/15563650.2024.2377268","volume":"62","author":"MJ Moss","year":"2024","unstructured":"Moss MJ, Hinchman B, Lambson JE, Scott JW, Wylie SJ, Dorey A. Assessment of high-dose acetylcysteine in acute high-risk Paracetamol (acetaminophen) ingestion. Clin Toxicol. 2024;62(8):519\u201325. https:\/\/doi.org\/10.1080\/15563650.2024.2377268.","journal-title":"Clin Toxicol"},{"issue":"7698","key":"1129_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0140-6736(71)91125-1","volume":"297","author":"LF Prescott","year":"1971","unstructured":"Prescott LF, Roscoe P, Wright N, Brown SS. Plasma-paracetamol half-life and hepatic necrosis in patients with Paracetamol overdosage. Lancet. 1971;297(7698):519\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(71)91125-1.","journal-title":"Lancet"},{"key":"1129_CR21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1136\/bmj.2.6198.1097","volume":"2","author":"LF Prescott","year":"1979","unstructured":"Prescott LF, Illingworth RN, Stewart MJ, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for Paracetamol poisoning. Br Med J. 1979;2:1097\u2013100. https:\/\/doi.org\/10.1136\/bmj.2.6198.1097.","journal-title":"Br Med J"},{"issue":"3","key":"1129_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/archinte.1981.00340030112020","volume":"141","author":"BH Rumack","year":"1981","unstructured":"Rumack BH, Peterson RC, Koch GG, Amara I. Acetaminophen overdose: 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med. 1981;141(3):380\u20135.","journal-title":"Arch Intern Med"},{"issue":"8705","key":"1129_CR23","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/0140-6736(90)91388-Q","volume":"335","author":"PM Harrison","year":"1990","unstructured":"Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet. 1990;335(8705):1572\u20133. https:\/\/doi.org\/10.1016\/0140-6736(90)91388-Q.","journal-title":"Lancet"},{"issue":"1","key":"1129_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0022-3476(98)70501-3","volume":"132","author":"HE Perry","year":"1998","unstructured":"Perry HE, Shannon MW. Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial. J Pediatr. 1998;132(1):149\u201352. https:\/\/doi.org\/10.1016\/s0022-3476(98)70501-3.","journal-title":"J Pediatr"},{"issue":"6","key":"1129_CR25","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.annemergmed.2023.07.024","volume":"82","author":"JJ Oskvarek","year":"2023","unstructured":"Oskvarek JJ, Zocchi MS, Black BS, et al. Emergency department volume, severity, and crowding since the onset of the coronavirus disease 2019 pandemic. Ann Emerg Med. 2023;82(6):650\u201360. https:\/\/doi.org\/10.1016\/j.annemergmed.2023.07.024.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"1129_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E Von Elm","year":"2008","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"key":"1129_CR27","doi-asserted-by":"publisher","first-page":"100288","DOI":"10.1016\/j.eclinm.2020.100288","volume":"20","author":"A Wong","year":"2020","unstructured":"Wong A, Isbister G, McNulty R, et al. Efficacy of a two bag acetylcysteine regimen to treat Paracetamol overdose (2NAC study). EClinicalMedicine. 2020;20:100288. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100288.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"1129_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/emermed-2021-212180","volume":"40","author":"C Humphries","year":"2023","unstructured":"Humphries C, Roberts G, Taheem A, Abdel Kader H, Kidd R, Smith J. SNAPTIMED study: does the Scottish and Newcastle antiemetic protocol achieve timely intervention and management from the emergency department to discharge for Paracetamol poisoning? Emerg Med J. 2023;40(3):221\u20133. https:\/\/doi.org\/10.1136\/emermed-2021-212180.","journal-title":"Emerg Med J"},{"key":"1129_CR29","first-page":"343","volume":"186","author":"K Pearson","year":"1895","unstructured":"Pearson K. Contributions to the mathematical theory of evolution, II: skew variation in homogenous material. Trans R Philos Soc Ser A. 1895;186:343\u2013414.","journal-title":"Trans R Philos Soc Ser A"},{"key":"1129_CR30","doi-asserted-by":"publisher","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Routledge; 2013. https:\/\/doi.org\/10.4324\/9780203771587.","DOI":"10.4324\/9780203771587"},{"issue":"3","key":"1129_CR31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/00031305.1948.10501587","volume":"2","author":"GW Brown","year":"1948","unstructured":"Brown GW, Mood AM. Homogeneity of several samples. Am Stat. 1948;2(3):22\u20133.","journal-title":"Am Stat"},{"issue":"2","key":"1129_CR32","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1213\/ANE.0000000000004535","volume":"130","author":"SJ Staffa","year":"2020","unstructured":"Staffa SJ, Zurakowski D. Calculation of confidence intervals for differences in medians between groups and comparison of methods. Anesth Analg. 2020;130(2):542\u20136. https:\/\/doi.org\/10.1213\/ANE.0000000000004535.","journal-title":"Anesth Analg"},{"issue":"7","key":"1129_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ajem.2004.08.017","volume":"22","author":"BK Adams","year":"2004","unstructured":"Adams BK, Mann MD, Aboo A, Isaacs S, Evans A. Prolonged gastric emptying half-time and gastric hypomotility after drug overdose. Am J Emerg Med. 2004;22(7):548\u201354. https:\/\/doi.org\/10.1016\/j.ajem.2004.08.017.","journal-title":"Am J Emerg Med"},{"issue":"6","key":"1129_CR34","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/bcp.13214","volume":"83","author":"DJB Marks","year":"2017","unstructured":"Marks DJB, Dargan PI, Archer JRH, et al. Outcomes from massive Paracetamol overdose: a retrospective observational study. Br J Clin Pharmacol. 2017;83(6):1263\u201372. https:\/\/doi.org\/10.1111\/bcp.13214.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"1129_CR35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/15563650.2021.1979231","volume":"60","author":"KR Shah","year":"2022","unstructured":"Shah KR, Beuhler MC. Single bag high dose intravenous N-acetylcysteine associated with decreased hepatotoxicity compared to triple bag intravenous N-acetylcysteine in high-risk acetaminophen ingestions. Clin Toxicol. 2022;60(4):493\u20138. https:\/\/doi.org\/10.1080\/15563650.2021.1979231.","journal-title":"Clin Toxicol"},{"issue":"10","key":"1129_CR36","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1080\/15563650.2021.1887493","volume":"59","author":"JW Downs","year":"2021","unstructured":"Downs JW, Cumpston KL, Kershner EK, Troendle MM, Rose SR, Wills BK. Clinical outcome of massive acetaminophen overdose treated with standard-dose N-acetylcysteine. Clin Toxicol. 2021;59(10):932\u20136. https:\/\/doi.org\/10.1080\/15563650.2021.1887493.","journal-title":"Clin Toxicol"},{"issue":"1","key":"1129_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/bcp.15199","volume":"89","author":"HKR Thanacoody","year":"2023","unstructured":"Thanacoody HKR. Large Paracetamol overdose \u2013 Higher dose NAC is NOT required. Br J Clin Pharmacol. 2023;89(1):39\u201342. https:\/\/doi.org\/10.1111\/bcp.15199.","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-026-01129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-026-01129-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-026-01129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:30:31Z","timestamp":1781641831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-026-01129-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1129"],"URL":"https:\/\/doi.org\/10.1007\/s13181-026-01129-5","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author CJW discloses that he received additional subaward fundingover the past three years, unrelated to this project: the National Institutes of Health \/ NationalInstitute on Drug Abuse, Grant Number R25DA58490 (American College of Medical ToxicologyANTIDOTE Institute). He has additional subaward funding pending, unrelated to this project: TheNational Institutes of Health \/ National Institute of General Medical Sciences, Grant NumberP20GM139745 (COBRE in Acute Care Research & Rural Health).\u00a0Author MDS discloses that hereceived additional subaward funding over the past three years, unrelated to this project: theNational Institutes of Health \/ National Institute on Drug Abuse, Grant Number R25DA58490(American College of Medical Toxicology ANTIDOTE Institute).\u00a0Author MMB discloses that shereceives payment as Pediatric Toxicology Section Editor from UpToDate.\u00a0Authors NS, CAW, MBY,MJN, KES, and TDS declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}